ENZ Stock Price Chart More Charts

ENZ Price/Volume Stats

Enzo Biochem, Inc. ($0.01 Par Value) (ENZ) Company Bio

Enzo Biochem, Inc. engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company was founded in 1976 and is based in New York, New York.

ENZ Price Forecast Based on DCF Valuation

We started the process of determining a valid price forecast for Enzo Biochem Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Enzo Biochem Inc ranked in the 0st percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Enzo Biochem Inc ended up being:

• The company's compound free cash flow growth rate over the past 4.01 years comes in at -0.45%; that's greater than only 2.48% of US stocks we're applying DCF forecasting to.
• As a business, Enzo Biochem Inc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than only 0% of stocks generating free cash flow.

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as ENZ, try AGHC, ALC, CSII, HAPP, and MGTX.